
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1085 | 1085 | 1135 | 1230 | 1654 | 1334 |
Fund Return | 8.52% | 8.52% | 13.52% | 7.15% | 10.59% | 2.93% |
Place in category | 107 | 107 | 62 | 188 | 222 | 152 |
% in Category | 37 | 37 | 20 | 64 | 82 | 85 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Santander Select Decidido S FI | 5.84B | -1.84 | 1.50 | 1.93 | ||
Santander Select Decidido A FI | 5.84B | -1.84 | 1.50 | 1.82 | ||
Santander 100 Valor Creciente 2 FI | 2.9B | 0.99 | 1.93 | - | ||
Santander Select Patrimonio S FI | 2.47B | -0.75 | 0.79 | -0.03 | ||
Santander Select Patrimonio A FI | 2.47B | -0.75 | 0.79 | -0.14 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
BBVA Mi Inversion Bolsa FI | 527.3M | 5.15 | 7.15 | 2.52 | ||
ES0109360026 | 417.43M | 8.78 | 8.22 | - | ||
Santander Dividendo Europa A FI | 417.43M | 8.39 | 6.61 | 2.41 | ||
Santander Dividendo Europa D FI | 417.43M | 8.52 | 6.98 | - | ||
Ibercaja Dividendo A FI | 307.34M | 4.87 | 8.37 | 4.22 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Roche Holding Participation | CH0012032048 | 7.31 | 243.80 | +0.33% | |
Sanofi | FR0000120578 | 4.25 | 89.62 | +0.64% | |
AXA | FR0000120628 | 4.11 | 37.13 | -0.19% | |
Reckitt Benckiser | GB00B24CGK77 | 3.84 | 4,766.0 | +0.13% | |
TotalEnergies SE | FR0000120271 | 3.81 | 48.67 | -1.72% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review